Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- CORPORATE ROUNDUP NEWS IN BRIEF -1-
November 26, 2001
- RESEARCH AND DEVELOPMENT NEWS IN BRIEF
November 26, 2001
- CORPORATE ROUNDUP NEWS IN BRIEF -3-
November 26, 2001
- OTC NEWS IN BRIEF
November 26, 2001
- Daiichi Considers Independent Marketing in Europe: President Morita
November 26, 2001
- Top 10 Companies Report Bullish Interim Results
November 26, 2001
- MPC to Complete Marketing Line Integration by March
November 26, 2001
- Toru Nagashima Appointed New President at Teijin
November 26, 2001
- BUSINESS NEWS IN BRIEF
November 26, 2001
- Remicade, Simulect Designated as Orphans
November 26, 2001
- Pressure on Medical Fees Gains Momentum
November 26, 2001
- LDP Summarizes Its Proposals for Healthcare Reform
November 26, 2001
- Takeda to Set Up Facility for Gene, Protein Function Analysis
November 19, 2001
- Mitsubishi Research Institute Launches Coding Software Based on Ethical GL
November 19, 2001
- RESEARCH AND DEVELOPMENT NEWS IN BRIEF
November 19, 2001
- BUSINESS NEWS IN BRIEF
November 19, 2001
- Greencross-coa: Sales Up 21% to \23.4 Bil.
November 19, 2001
- OBITUARY
November 19, 2001
- DIAGNOSTIC NEWS IN BRIEF
November 19, 2001
- Industry Fights Price Cuts of Original Products: Chuikyo
November 19, 2001
ページ
Japan’s pharmaceutical industry could be on the verge of gaining a stronger voice in the Central Social Insurance Medical Council…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…